Loss of <i>CDX2</i> and high COX2 (<i>PTGS2</i>) expression in metastatic colorectal cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Álvaro M C,Caldas ^[1] ; Warley A,Nunes ^[2] ; Rodrigo,Taboada ^[1] ; Marcelle G,Cesca ^[1] ; Janaína N,Germano ^[3] ; Rachel P,Riechelmann ^[1]

作者单位： Department of Clinical Oncology, AC Camargo Cancer Center, São Paulo 01509-900, Brazil. ^[1] Department of Pathology, AC Camargo Cancer Center, São Paulo 01509-900, Brazil. ^[2] Statistic Group at the International Research Center (CIPE), AC Camargo Cancer Center, São Paulo 01509-900, Brazil. ^[3]

关键词 BRAF CDX2 COX2 chemotherapy metastatic colorectal cancer

DOI 10.3332/ecancer.2024.1666

PMID 38439814

发布时间 2024-03-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Ecancermedicalscience

2024年18卷

1666页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Loss of <i>CDX2</i> and high COX2 (<i>PTGS2</i>) expression in metastatic colorectal cancer.

Ecancermedicalscience

相似文献

Ecancermedicalscience

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Loss of <i>CDX2</i> and high COX2 (<i>PTGS2</i>) expression in metastatic colorectal cancer.

Ecancermedicalscience

相似文献

Ecancermedicalscience

相关期刊

检索历史清除